Abstract:Background: Non-small cell lung cancer (NSCLC) is associated with a high mortality and morbidity rate. MicroRNAs participate in tumorigenesis, progression and metastasis of NSCLC. However, miR-6884-5p has not been previously studied. This study aimed to investigate the role of miR-6884-5p in NSCLC and explore its underlying mechanisms. Methods: We used miR-6884-5p mimics and inhibitors to assess its effects in NSCLC. miR-6884-5p expression levels in NSCLC cell lines were quantified using qRT-PCR. Cell viability was determined using a cell-counting kit 8 assay. Western blot analysis was employed to measure apoptotic proteins. The impact of miR-6884-5p on cell proliferation was assessed via colony formation assay. Furthermore, Transwell assays were utilized to visualize and quantify the effects of miR-6884-5p on NSCLC migration and invasion. Results: miR-6884-5p mimic significantly inhibited NSCLC cell proliferation to 71.21 % and 72.26 % of control at 5 days of culture time in H460 and HC9 cells (both p < 0.01), respectively, while miR-6884-5p inhibitor significantly promoted cell proliferation to 119.66 % and 126.44 % of control at 5 days of culture time in H460 and HC9 cells (both p < 0.05), respectively. In addition, miR-6884-5p promoted apoptosis by reducing the anti-apoptotic protein B-cell lymphoma 2 (BCL2) protein and increasing apoptotic protein BCL2 associated X protein (all p < 0.01 at least). Moreover, miR-6884-5p effectively suppressed transforming growth factor β1-induced epithelial-mesenchymal transition, as evidenced by the restored expression of E-cadherin (p < 0.01), N-cadherin (p < 0.01) and Vimentin (p < 0.05), leading to the inhibition of migration and invasion in NSCLC cell lines. Conclusions: Our findings demonstrate that miR-6884-5p can inhibit NSCLC cell proliferation, migration, and invasion, suggesting its potential as a therapeutic target for NSCLC treatment.

Downregulation of Mir‐3127‐5p Promotes Epithelial‐mesenchymal Transition Via FZD4 Regulation of Wnt/β‐catenin Signaling in Non‐small‐cell Lung Cancer

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Mir-335-5p Inhibits TGF-β1-induced Epithelial–mesenchymal Transition in Non-Small Cell Lung Cancer Via ROCK1

MicroRNA‐331‐3p Inhibits Epithelial‐mesenchymal Transition by Targeting ErbB2 and VAV2 Through the Rac1/PAK1/β‐catenin Axis in Non‐small‐cell Lung Cancer

Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling

Decreased Expression of Mir216a Contributes to Non-Small-Cell Lung Cancer Progression

Effects of Mir-132-3p on Progress and Epithelial Mesenchymal Transition of Non-Small Cell Lung Cancer Via Regulating KLF7

MiR‐182 Inhibits the Epithelial to Mesenchymal Transition and Metastasis of Lung Cancer Cells by Targeting the Met Gene

MicroRNA-4458 suppresses migration and epithelial-mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells.

Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Ccl18-Mediated Down-Regulation of Mir98 and Mir27b Promotes Breast Cancer Metastasis

Mir-367 Promotes the Proliferation and Invasion of Non-Small Cell Lung Cancer Via Targeting FBXW7.

[Epithelial-Mesenchymal Transition (EMT) and Its Effect on Microrna Expression in Lung Cancer].

MicroRNA-34a/EGFR Axis Plays Pivotal Roles in Lung Tumorigenesis

Down-Regulation of Mir-4500 Promoted Non-Small Cell Lung Cancer Growth

Mir‑146a‑5p Targets TCSF and Influences Cell Growth and Apoptosis to Repress NSCLC Progression

MicroRNAs target the Wnt/β-catenin signaling pathway to regulate epithelial-mesenchymal transition in cancer

miR-6884-5p inhibits proliferation and epithelial-mesenchymal transition in non-small cell lung cancer cells

Mir-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting Rhogdi1 and Alcam

Mir-367 Promotes Tumor Growth by Inhibiting FBXW7 in NSCLC.